Home›Drug Pipeline› Stathmin implicated in cancer and non-neoplastic diseases, potential biomarker and therapeutic target
Stathmin implicated in cancer and non-neoplastic diseases, potential biomarker and therapeutic targetStathmin Linked to Cancer Growth and Tissue Repair Processes
Frontiers in MedicinePublished August 24, 2026DOI ↗Editorial oversight: Dr. Julia Lee, PhD · Oncology, Genomics & Drug Development
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider stathmin as a potential biomarker or target, but await clinical validation.
This systematic review synthesizes the current understanding of stathmin, a microtubule-destabilizing protein, across a broad range of diseases. The review covers stathmin's roles in cytoskeletal dynamics, cell division, migration, differentiation, and intracellular signal transduction, and extends to its involvement in skin and mucosal repair, neurological function, metabolic homeostasis, pulmonary fibrosis, and pregnancy maintenance.
Key findings indicate that stathmin promotes microtubule depolymerization, a fundamental process affecting cell division and migration. Aberrant stathmin expression or activity is strongly implicated in cancer cell proliferation, invasion, metastasis, and chemoresistance. In non-neoplastic diseases, stathmin orchestrates skin and mucosal repair, maintains neurological function, influences pulmonary fibrosis, modulates metabolic homeostasis, and supports pregnancy maintenance.
The review highlights stathmin's potential as a diagnostic biomarker and a promising therapeutic target. However, these are potential applications; no clinical trial data are provided. The evidence is largely associative, describing biological roles rather than causal relationships. Limitations were not reported in the source, and the certainty of evidence is not specified.
For clinicians, these findings suggest that stathmin may eventually serve as a biomarker or target, but current evidence is preclinical and associative. Clinical application awaits further validation in prospective studies.
How this fits prior evidence
This systematic review extends prior coverage by addressing a molecular mechanism that could underlie multiple disease processes. It confirms the importance of targeted pathways in cancer, as seen with IL-17 and mRNA vaccines, but focuses on a novel protein, stathmin. It also broadens the scope to non-neoplastic conditions, contrasting with prior coverage that centered on cancer-specific interventions. The review addresses a gap by synthesizing stathmin's roles across diverse diseases, though it does not provide clinical efficacy data, unlike the virtual treatment trial reporting a 28.4% abstinence rate.
This review looked at how a protein called stathmin affects different parts of the body. Researchers found that stathmin helps manage the structure of cells by influencing microtubules. This process is important for many basic functions, such as cell division and movement.
In some cases, abnormal levels of stathmin are linked to cancer. Specifically, it has been associated with how cancer cells grow, spread, and resist treatment. Because of this link, scientists see stathmin as a potential target for future medical treatments or ways to identify certain conditions.
Stathmin also plays important roles in healthy tissues. It helps repair skin and mucous membranes, supports neurological functions, and may influence how the body handles lung fibrosis and metabolism. While these findings show that stathmin is very active in many systems, this research is a review of biological roles rather than a clinical trial. There are no current reports on human safety or specific drug treatments.
What this means for you:
Stathmin is linked to both cancer progression and the repair of skin and lung tissues.
Common questions
What is the link between stathmin and cancer?
Abnormal stathmin activity or expression is strongly linked to how cancer cells multiply, invade other tissues, spread, and resist chemotherapy. Because of these links, researchers believe stathmin could eventually serve as a way to diagnose issues or as a target for new treatments.
Does stathmin help with tissue repair?
Yes, the research indicates that stathmin helps orchestrate the repair of skin and mucosal membranes. It is also involved in maintaining neurological functions and managing metabolic homeostasis within the body.
Can stathmin be used to treat lung disease?
The review shows that stathmin influences pulmonary fibrosis and supports pregnancy maintenance. However, this is a review of biological roles, not a clinical trial, so it does not provide specific medical advice or treatment plans for lung conditions.
Stathmin, a highly conserved microtubule-destabilizing protein in eukaryotes, plays a pivotal role in regulating cytoskeletal dynamics by promoting microtubule depolymerization. This process is indispensable for fundamental biological events, including cell division, migration, differentiation, and intracellular signal transduction. This review systematically elucidates stathmin’s genomic architecture, molecular functions, and mechanistic contributions under both physiological and pathological contexts. The functional output of stathmin is tightly modulated by post-translational modifications, particularly phosphorylation, as well as its protein expression levels. Aberrant stathmin expression or activity is strongly implicated in tumorigenesis, driving cancer cell proliferation, invasion, metastasis, and chemoresistance. Conversely, in non-neoplastic diseases, stathmin orchestrates skin and mucosal repair, maintains neurological function, influences pulmonary fibrosis, modulates metabolic homeostasis, and supports pregnancy maintenance through its cytoskeletal regulatory capacity. Furthermore, this study highlights stathmin’s significant potential as a diagnostic biomarker and a promising therapeutic target. Finally, we propose future research directions that prioritize deciphering tissue-specific regulatory mechanisms and accelerating the translation of basic scientific discoveries into clinical applications.
